Skip to content
10-Q

Quarterly Report

NP Life Sciences Health Industry Group Inc. ACAT

0001493152-22-022753

← back to feed
Filed
Aug 15, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Jun 30, 2022 42.96M sh
Cash And Equivalents Q2 2022 · Jun 30, 2022 $575
Cash And Equivalents Q2 2022 · Dec 31, 2021 $27.99K
Total Liabilities Q2 2022 · Jun 30, 2022 $8.88K
Total Liabilities Q2 2022 · Dec 31, 2021 $239
Total Assets Q2 2022 · Jun 30, 2022 $17.04K
Total Assets Q2 2022 · Dec 31, 2021 $38.41K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$77.88K
Stockholders Equity Q2 2022 · Jun 30, 2021 $26.86K
Stockholders Equity Q2 2022 · Dec 31, 2020 $103.85K
Sga Expense Q2 2022 · Jun 30, 2021 $52.74K
Sga Expense Q2 2022 · Jun 30, 2021 $76.99K
Net Income Q2 2022 · Jun 30, 2021 −$52.74K
Net Income Q2 2022 · Jun 30, 2021 −$76.99K
Operating Income Q2 2022 · Jun 30, 2021 −$52.74K
Operating Income Q2 2022 · Jun 30, 2021 −$76.99K